Results 11 to 20 of about 16,685 (240)

A Twist in the Tale: The Unmasking of Listeria in a PMR Case

open access: yesClinical Case Reports
In general, an older patient presenting with proximal muscle pain and fatigue, with elevated inflammatory markers, would generally result in an extensive evaluation.
Ghassan Al‐Qaysi   +3 more
doaj   +2 more sources

Recommendations for early referral of individuals with suspected polymyalgia rheumatica: an initiative from the international giant cell arteritis and polymyalgia rheumatica study group

open access: yesAnnals of the Rheumatic Diseases, 2023
Objective To develop international consensus-based recommendations for early referral of individuals with suspected polymyalgia rheumatica (PMR). Methods A task force including 29 rheumatologists/internists, 4 general practitioners, 4 patients and a ...
K. Keller   +37 more
semanticscholar   +1 more source

Polymyalgia rheumatica presenting as sternoclavicular arthritis: a case report

open access: yesJournal of Medical Case Reports, 2022
Background Polymyalgia rheumatica and giant cell arteritis are systemic inflammatory conditions of the elderly. Polymyalgia rheumatica classically presents as a bilateral proximal muscle pain and stiffness syndrome.
Liyana Arachchige Dona Thulini Madubashini   +2 more
doaj   +1 more source

Role of 18F-FDG PET/CT in Large Vessel Vasculitis and Polymyalgia Rheumatica

open access: yesJournal of Nuclear Medicine, 2023
Systemic vasculitides comprise a group of autoimmune diseases affecting blood vessels, including large vessel vasculitis (LVV) and medium-sized vessel vasculitis such as giant cell arteritis (GCA) and Takayasu arteritis (TAK).
R. Slart   +5 more
semanticscholar   +1 more source

Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia Rheumatica Receiving Glucocorticoid Therapy: A Randomized Clinical Trial.

open access: yesJournal of the American Medical Association (JAMA), 2022
Importance Few treatments are available for patients with glucocorticoid-dependent polymyalgia rheumatica. IL-6 antagonists may reduce disease activity in patients with active glucocorticoid-dependent polymyalgia rheumatica.
V. Devauchelle-Pensec   +21 more
semanticscholar   +1 more source

Subclinical giant cell arteritis in new onset polymyalgia rheumatica A systematic review and meta-analysis of individual patient data.

open access: yesSeminars in Arthritis & Rheumatism, 2022
OBJECTIVES To determine the prevalence and predictors of subclinical giant cell arteritis (GCA) in patients with newly diagnosed polymyalgia rheumatica (PMR). METHODS PubMed, Embase, and Web of Science Core Collection were systematically searched (date
A. Hemmig   +24 more
semanticscholar   +1 more source

Differential diagnostics of polymyalgia rheumatica in a university hospital in Finland

open access: yesScandinavian Journal of Rheumatology, 2023
Objectives Diagnosing polymyalgia rheumatica (PMR) can be difficult as many conditions present with similar symptoms and findings. This study aimed to analyse how often the diagnosis of PMR changes during follow-up in a university hospital setting and to
J. Paltta   +3 more
semanticscholar   +1 more source

Polymyalgia rheumatica

open access: yesDeutsches Ärzteblatt international, 2022
Polymyalgia rheumatica (PMR) is among the most common inflammatory rheumatic diseases in older adults. Presumed risk factors include female sex, previous infections, and genetic factors. No epidemiological data on PMR in Germany have been available until now.This review is based on publications retrieved by a selective literature search in PubMed ...
Miriam Giovanna, Colombo   +5 more
openaire   +2 more sources

Polymyalgia Rheumatica [PDF]

open access: yesJournal of the Royal College of Physicians of London, 1969
Giant cell arteritis-mediated polymyalgia rheumatica is a typical disease of old age; though manifestation is rare in patients younger than 50 years, there is no upper age limit. Average disease-onset is at age 70. Typical symptoms and high serological inflammation are found.
  +12 more sources

Home - About - Disclaimer - Privacy